Projects per year
Personal profile
Personal profile
Dr. Aparna Kamat is the director of the Division of Gynecologic Oncology for Houston Methodist and is currently the section leader for the Gynecologic Oncology service line. After completing medical training in India, Dr. Kamat completed her residency in OB/GYN at West Virginia University where she served as chief resident.
She completed her fellowship training in Gynecologic Oncology at the MD Anderson Cancer Center. During her fellowship, she received multiple awards for her research in ovarian cancer and endometrial cancer including the Virginia K. Pierce award and the Asche Murray fellowship. She also received the prestigious BIRCWH award from the N.I.H. for her research in biomarkers for ovarian cancer. Dr. Kamat currently is the principle investigator for the Gynecologic Oncology Group Clinical Trials Program at Houston Methodist and offers several state-of-the-art clinical trials for patients with gynecologic malignancies.
Her areas of expertise are robotic and minimally invasive surgical options for women with gynecologic cancers and complex pelvic disease. Her other clinical interests include hereditary risk assessment and treatment of gynecologic malignancies.
Research Area Keywords
- Cancer
Free-text keywords
- Gynecologic cancer
- Pelvic disease
- Hereditary risk assessment
- Minimally invasive surgery
- Gynecologic malignancy
Fingerprint
Dive into the research topics where Aparna A. Kamat is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
ARIA II: A Phase III Randomized Controlled Trial of Near-Infrared Angiography During Rectosigmoid Resection and Anastomosis in Women with Ovarian Cancer.
Zaid, T. (PI), Kamat, A. A. (Key Personnel), Ramirez, P. T. (Key Personnel), Snyder, M. J. (Key Personnel) & Suri, A. (Key Personnel)
1/13/25 → …
Project: Clinical Trial
-
A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy With No Retroperitoneal Node Dissection in Apparent Early-Stage Endometrial Cancer
Kamat, A. A. (Key Personnel), Ramirez, P. T. (Key Personnel), Suri, A. (Key Personnel) & Zaid, T. (Key Personnel)
7/24/24 → …
Project: Clinical Trial
-
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
Ramirez, P. T. (PI), Kamat, A. A. (Key Personnel), Suri, A. (Key Personnel) & Zaid, T. (Key Personnel)
3/7/24 → …
Project: Clinical Trial
-
An Open-Label Randomized Active-Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-ResistantOvarian Cancer
Kamat, A. A. (PI), Darcourt, J. (CoI), Singh, M. (CoI), Suri, A. (CoI) & Zaid, T. (CoI)
3/15/21 → 3/14/46
Project: Non Profit
-
Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in Bioengineered In Vitro Models of Ovarian Cancer
VandenHeuvel, S. N., Chau, E., Mohapatra, A., Dabbiru, S., Roy, S., O’Connell, C., Kamat, A., Godin, B. & Raghavan, S. A., Dec 16 2024, In: ACS Applied Bio Materials. 7, 12, p. 7871-7882 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Ovarian Cancer
Hanafy, A. K., Morani, A. C., Jensen, C. T., Kamat, A., Eifel, P. J. & Bhosale, P. R., Jan 1 2022, Oncologic Imaging: A Multidisciplinary Approach. Elsevier, p. 452-475 24 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
The Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine
O’Connell, C., VandenHeuvel, S., Kamat, A., Raghavan, S. & Godin, B., Sep 1 2022, In: International journal of molecular sciences. 23, 17, 9981.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma (Nature Medicine, (2006), 12, 8, (939-944), 10.1038/nm1447)
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., Merritt, W. M., Lin, Y. G., Mangala, L. S., Kim, T. J., Coleman, R. L., Landen, C. N., Li, Y., Felix, E., Sanguino, A. M. & Newman, R. A. & 7 others, , Dec 2021, In: Nature Medicine. 27, 12, p. 2246 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access8 Scopus citations -
Editor's Note: The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer
Kamat, A. A., Fletcher, M., Gruman, L. M., Mueller, P., Lopez, A., Landen, C. N., Han, L., Gershenson, D. M. & Sood, A. K., Aug 1 2021, In: Clinical Cancer Research. 27, 15, p. 4455 1 p.Research output: Contribution to journal › Article › peer-review